Clinical Trials
All Clinical Trials - Page 9 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT07280221N/AEnrolling By Invitation
WEgovy Real World Assessment of Weight Loss in Korea
Semaglutide
- NCT07225816Phase 1Recruiting
Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
Semaglutide
- NCT07202247Phase 2Recruiting
Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial
Tirzepatide
- NCT05933499Phase 2Recruiting
Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity
Tirzepatide
- NCT07220642Phase 3Active Not Recruiting
Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide
Cagrilintide
- NCT07220759Phase 3Active Not Recruiting
Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide
Cagrilintide
- NCT07221591Phase 1Completed
A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body
Survodutide
- NCT07245771Phase 1/Phase 2Recruiting
Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and Obesity
Tirzepatide
- NCT07223593Phase 3Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Orforglipron
- NCT07128082Phase 2Active Not Recruiting
The Long COVID Treatment Trial
Tirzepatide
- NCT07229157Phase 1Completed
Effect of Maridebart Cafraglutide on the Heart's Electrical Activity
Maridebart-Cafraglutide
- NCT07820111Phase 3Completed
Comparative Study of Different Weekly GLP-1 Receptor Agonists Among Diabetic and Non-Diabetic Patients: Clinical Trial
Tirzepatide
- NCT07165028Phase 3Recruiting
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Retatrutide
- NCT07226778Phase 1Completed
Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous (SC) Presentations
Maridebart-Cafraglutide
- NCT07154719Phase 4Recruiting
GLP-1R Actions on Muscle and the Skeleton
Tirzepatide
- NCT06994338Phase 2Recruiting
Tirzepatide for Alcohol Use Disorder
Tirzepatide
- NCT07159451Phase 2Recruiting
A Short-term Preoperative, Evaluating Activity and Safety of Elacestrant Monotherapy as Compared to Elacestrant + Ovarian Function Suppression (LHRH Agonist) in Premenopausal Patients With Stage I-II ER+/HER2- Breast Cancer
Gonadorelin
- NCT06976619Phase 2Recruiting
The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes
Liraglutide
- NCT07156331N/ANot Yet Recruiting
Research on Effects of Drugs on Body Composition and Function With Imaging in Diabetes
Tirzepatide
- NCT06801015Phase 4Active Not Recruiting
Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions
Tirzepatide
- NCT07103408Phase 2Not Yet Recruiting
A Study Evaluating Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade for Limited-stage Small Cell Lung Cancer
Thymosin-Alpha-1
- NCT07242612N/ACompleted
Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis
Teriparatide
- NCT06909006Phase 3Not Yet Recruiting
Semaglutide Treatment in Type 1 Diabetes
Semaglutide
- NCT07156539Phase 3Not Yet Recruiting
A Phase 3 Study of HS-20094 in Patients With T2DM
Dulaglutide
- NCT07135141N/ANot Yet Recruiting
Mazdutide as Adjuvant Therapy Following Sleeve Gastrectomy in Severe Obesity
Mazdutide
- NCT07202884Phase 3Recruiting
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
Orforglipron
- NCT07879833N/ACompleted
AI-Personalized Skincare Regimen for Facial Photoaging in Women
GHK-Cu
- NCT07083154Phase 3Recruiting
Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)
Mazdutide
- NCT07154238N/AEnrolling By Invitation
Characteristics and Treatment Experiences of Individuals Using Injectable Semaglutide for Weight Management, a Cross-sectional Time-series Analysis, Multi-country Study.
Semaglutide
- NCT07184086Phase 1Active Not Recruiting
A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet
Semaglutide
- NCT06441331Phase 1Recruiting
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
Octreotide
- NCT07200622Phase 2Not Yet Recruiting
Oral Semaglutide in Patients With Alzheimer's Disease
Semaglutide
- NCT07150975Phase 3Recruiting
Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects
Semaglutide
- NCT07216651N/ACompleted
WeDosify Real World Evidence (RWE) Study: Personalized Semaglutide Dosing in U.S. Adults
Semaglutide
- NCT06760546Phase 3Recruiting
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
Setmelanotide
- NCT07203677N/ACompleted
Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)
Tirzepatide
- NCT06847399Phase 2Recruiting
Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder
Tirzepatide
- NCT06727331Phase 2Recruiting
Study of Tirzepatide for Recovery and Alcohol Use Management
Tirzepatide
- NCT07188545N/AActive Not Recruiting
Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)
Tirzepatide
- NCT07156591N/ANot Yet Recruiting
Impact of Neuropathy on the Risk of Semaglutide-Induced Gastric Retention
Semaglutide
- NCT07152756N/ANot Yet Recruiting
Impact of a One-Week Discontinuation of Semaglutide on Gastric Retention and Endoscopic Mucosal Visibility Scores
Semaglutide
- NCT07165158Phase 4Not Yet Recruiting
The Effect of Semaglutide on Bone Health
Semaglutide
- NCT07035704N/ANot Yet Recruiting
Prevent and Reverse Obesity in Children, Adolescents and Young Adults
Semaglutide
- NCT07153471Phase 3Active Not Recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
Orforglipron
- NCT07152730Phase 1Withdrawn
A Study to Measure Pharmacokinetic (PK) Concentrations of Gonadotropin-Releasing Hormone Delivered by the OmniPod Pump
Gonadorelin
- NCT07136714Phase 4Recruiting
Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity
Semaglutide
- NCT07169136N/ARecruiting
Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)
Semaglutide
- NCT07091734Phase 2Recruiting
Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024
Tirzepatide
- NCT07314684Phase 4Recruiting
GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM
Semaglutide
- NCT07752381N/ACompleted
A Clinical Trial to Evaluate the Effects of Peptide Gummies on Markers of Inflammation, Physical Performance, and Recovery
BPC-157